Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v10.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47842)
CDC/NIH Web Information Database (32258)
CDC-Authored Genomics and Precision Health Publications Database (6271)
Precision Health Database (64281)
Pathogen Advanced Molecular Detection Database (27556)
All of Us Reports and Publications Database (923)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (231021)
Epigenetic Epidemiology Publications Database (23511)
Release Note
Contact Us
CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
CDC-Authored Genomics and Precision Health Publications Database
Last data update: Aug 26, 2024
. (Total: 6271 publications)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
Filtered By:
Select to fine-tune your search
Year
Journal
Records 1-19 (of 19 Records)
Query Trace:
Mishin VP[original query]
Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022
Nguyen HT
,
Chesnokov A
,
De La Cruz J
,
Pascua PNQ
,
Mishin VP
,
Jang Y
,
Jones J
,
Di H
,
Ivashchenko AA , Killian ML , Torchetti MK , Lantz K ,
Wentworth DE
,
Davis CT
,
Ivachtchenko AV ,
Gubareva LV
.
Antiviral Res 2023 217 105679
Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir.
Patel MC
,
Chesnokov A
,
Jones J
,
Mishin VP
,
De La Cruz JA
,
Nguyen HT
,
Zanders N
,
Wentworth DE
,
Davis TC
,
Gubareva LV
.
Antiviral Res 2021 188 105035
Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods.
Patel MC
,
Mishin VP
,
De La Cruz JA
,
Chesnokov A
,
Nguyen HT
,
Wilson MM
,
Barnes J
,
Kondor RJG
,
Wentworth DE
,
Gubareva LV
.
Antiviral Res 2020 182 104906
Detection of oseltamivir-resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test.
Hodges EN
,
Mishin VP
,
De la Cruz J
,
Guo Z
,
Nguyen HT
,
Fallows E ,
Stevens J
,
Wentworth DE
,
Davis CT
,
Gubareva LV
.
Influenza Other Respir Viruses 2019 13 (5) 522-7
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
Jorquera PA
,
Mishin VP
,
Chesnokov A
,
Nguyen HT
,
Mann B
,
Garten R
,
Barnes J
,
Hodges E
,
De La Cruz J
,
Xu X
,
Katz J
,
Wentworth DE
,
Gubareva LV
.
Sci Rep 2019 9 (1) 2676
A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.
Mishin VP
,
Baranovich T
,
Garten R
,
Chesnokov A
,
Abd Elal AI
,
Adamczyk M
,
LaPlante J , George KS ,
Fry AM
,
Barnes J
,
Chester SC ,
Xu X
,
Katz JM
,
Wentworth DE
,
Gubareva LV
.
J Clin Microbiol 2016 55 (1) 145-154
Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015.
Flannery B
,
Zimmerman RK ,
Gubareva LV
,
Garten RJ
,
Chung JR , Nowalk MP , Jackson ML , Jackson LA , Monto AS , Ohmit SE , Belongia EA , McLean HQ , Gaglani M , Piedra PA ,
Mishin VP
,
Chesnokov AP
,
Spencer S ,
Thaker SN
,
Barnes JR
,
Foust A
,
Sessions W
,
Xu X
,
Katz J
,
Fry AM
.
J Infect Dis 2016 214 (7) 1010-9
The molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses.
Yang H
,
Carney PJ
,
Mishin VP
,
Guo Z
,
Chang JC
,
Wentworth DE
,
Gubareva LV
,
Stevens J
.
J Virol 2016 90 (12) 5770-5784
Application of a Seven-Target Pyrosequencing Assay To Improve the Detection of Neuraminidase Inhibitor-Resistant Influenza A(H3N2) Viruses.
Tamura D
,
Okomo-Adhiambo M
,
Mishin VP
,
Guo Z
,
Xu X
,
Villanueva J
,
Fry AM
,
Stevens J
,
Gubareva LV
.
Antimicrob Agents Chemother 2015 59 (4) 2374-9
Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011
Nguyen HT
,
Nguyen T ,
Mishin VP
,
Sleeman K
,
Balish A
,
Jones J
,
Creanga A ,
Marjuki H
,
Uyeki TM
,
Nguyen DH , Nguyen DT , Do HT ,
Klimov AI
,
Davis CT
,
Gubareva LV
.
Emerg Infect Dis 2013 19 (12) 1963-71
The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses.
Mishin VP
,
Sleeman K
,
Levine M
,
Carney PJ
,
Stevens J
,
Gubareva LV
.
Antiviral Res 2013 101 93-6
Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment
Tamura D
,
Nguyen HT
,
Sleeman K
,
Levine M
,
Mishin VP
,
Yang H
,
Guo Z
,
Okomo-Adhiambo M
,
Xu X
,
Stevens J
,
Gubareva LV
.
Antimicrob Agents Chemother 2013 57 (12) 6141-6
Bioluminescence-based neuraminidase inhibition assay for monitoring influenza drug susceptibility in clinical specimens
Marjuki H
,
Mishin VP
,
Sleeman K
,
Okomo-Adhiambo M
,
Sheu TG
,
Guo L
,
Xu X
,
Gubareva LV
.
Antimicrob Agents Chemother 2013 57 (11) 5209-15
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Nguyen HT
,
Trujillo AA
,
Sheu TG
,
Levine M
,
Mishin VP
,
Shaw M
,
Ades EW
,
Klimov AI
,
Fry AM
,
Gubareva LV
.
Antiviral Res 2012 93 (3) 381-6
Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein
Alymova IV , Portner A ,
Mishin VP
,
McCullers JA , Freiden P , Taylor GL .
Glycobiology 2012 22 (2) 174-80
Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing.
Levine M
,
Sheu TG
,
Gubareva LV
,
Mishin VP
.
J Clin Microbiol 2011 49 (4) 1307-12
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro
Gubareva LV
,
Trujillo AA
,
Okomo-Adhiambo M
,
Mishin VP
,
Deyde VM
,
Sleeman K
,
Nguyen HT
,
Sheu TG
,
Garten RJ
,
Shaw MW
,
Fry AM
,
Klimov AI
.
Antivir Ther 2010 15 (8) 1151-9
Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective
Okomo-Adhiambo M
,
Sleeman K
,
Ballenger K
,
Nguyen HT
,
Mishin VP
,
Sheu TG
,
Smagala J
,
Li Y ,
Klimov AI
,
Gubareva LV
.
Viruses 2010 2 (10) 2269-2289
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays
Nguyen HT
,
Sheu TG
,
Mishin VP
,
Klimov AI
,
Gubareva LV
.
Antimicrob Agents Chemother 2010 54 (9) 3671-7
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Aug 26, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP